Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma

Liu Yuchan; Liu Lin; Meng Lingjian; Wu Ming; Wu Yi

doi:10.13407/j.cnki.jpp.1672-108X.2023.01.009

您当前的位置：

首页 >

文章列表页 >

Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma

更新时间：2023-04-14

- Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma
- Vol. 29, Issue 1, Pages: 27-30(2023)
- 作者机构：
  
  徐州医科大学附属医院,江苏,徐州,221000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2023.01.009
  CLC：
- Published：2023，
扫描看全文
Liu Yuchan, Liu Lin, Meng Lingjian, et al. Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma. [J]. 29(1):27-30(2023)
DOI：

Liu Yuchan, Liu Lin, Meng Lingjian, et al. Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma. [J]. 29(1):27-30(2023) DOI： 10.13407/j.cnki.jpp.1672-108X.2023.01.009.

摘要

目的:探讨槐杞黄颗粒在轻度持续期哮喘患儿的应用价值。方法:采用前瞻性随机对照研究方法

收集我院儿科门诊轻度持续期哮喘患儿60 例

按随机数表法分为槐杞黄组和对照组各30 例。对照组采用吸入性糖皮质激素(ICS) 治疗

槐杞黄组采用ICS+槐杞黄颗粒治疗

比较两组患儿治疗后1、3、6 个月的临床评价指标及儿童哮喘控制测试(C-ACT)评分

并监测治疗前后免疫球蛋白E(IgE)、白细胞介素(IL)-4、IL-17、呼出气一氧化氮(FeNO)、脉冲震荡肺功能(IOS)水平的变化。结果:与对照组相比

槐杞黄组治疗后3、6 个月临床症状改善较明显且C-ACT 评分较高(P 均<0.05)。治疗3 个月后

两组患儿IgE、IL-4、IL-17、FeNO、气道总阻力、外周弹性阻力、共振频率水平较治疗前降低

且槐杞黄组均低于对照组(P 均<0. 05);两组中心气道阻力与治疗前比较差异无统计学意义(P>0. 05)。结论:槐杞黄颗粒联合ICS 治疗儿童轻度持续期哮喘疗效更佳

可下调IgE、IL-4、IL-17 水平

减轻气道炎症

改善小气道功能。

Abstract

Objective: To study the application value of Huaiqihuang granules in children with mild persistent asthma. Methods: A prospective

randomized

controlled study method was used to collect 60 cases of children with mild persistent asthma who attended the pediatric clinic of our hospital. They were divided into two groups according to the random number table method

including the Huaiqihuang group ( treated with inhaled corticosteroids + Huaiqihuang granules) and the control group ( treated with inhaled corticosteroids)

30 cases for each. Comparing the clinical evaluation indicators and child asthma control Test (C-ACT) scores at 1

3 and 6 months after treatment

and monitoring the changes of IgE

IL-4

IL-17

exhaled nitric oxide (FeNO)

and impulsed pulmonary function (IOS) before and after treatment. Results: After 3

6 months of treatment in the two groups

the clinical symptoms of the Huaiqihuang group were significantly improved compared with those of the control group

and the C-ACT was the highest (P<0. 05). After 3 months of treatment

the levels of IgE

IL-4

IL-17

FeNO

total airway resistance

peripheral elastic resistance and resonance frequency in the two groups were significantly lower than before treatment

with the Huaiqihuang group significantly lower than control group (P<0. 05). There was no significant difference in central airway resistance in two groups compared with that before the treatment (P>0. 05). Conclusion: Huaiqihuang granules combined with inhaled corticosteroids has a better therapeutic effect on asthma

and can reduce airway inflammation

lower the level of eosinophils and improve small airway function by down-regulating IgE

IL-4

and IL-17.

关键词

哮喘槐杞黄儿童小气道功能免疫功能

Keywords

asthmaHuaiqihuang granuleschildrensmall airway functionmmune function

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Influencing Factors of Treatment Compliance in Children with Asthma in China

Comprehensive Evaluation of Inhaled Corticosteroids Suspensionin Children with Acute Asthma

Investigation of Antimicrobial Use in Parents of Children with Asthma in Qingdao Area

Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1

Characteristics of Sleep-Disordered Breathing in Children with Bronchial Asthma

Related Author

Luo Nan

Wang Ling

Yuan Xiaoping

郭蓉

Yu Yuncui

Wang Shu

He Xiaojing

Xiang Li

Related Institution

Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics

National Center for Children’s Health, China, Beijing Children’s Hospital, Capital Medical University

Shengjing Hospital of China Medical University

Qingdao Huangdao District Central Hospital, ShandongQingdao

The Affiliated Hospital of Qingdao University, Shandong Qingdao

⁰